Fluidigm

Fluidigm is a company that focuses on the immune response monitoring of patients who suffer from cancer, infection or autoimmune disease. It is a company that is improving lives, empowering customers to reveal meaningful insights in health and disease, identifying actionable markers to inform life decisions, and accelerating the development of more effective therapies.

The company focuses on unmet needs in translational and clinical research, including cancer, immunology and immunotherapy. Fluidigm provides an unprecedented view into health and disease through its combination of innovative mass cytometry, genomics solutions and tissue imaging, by harnessing the proprietary CyTOF® and microfluidics capabilities.

Fluidigm systems are depended on by Researchers to uncover important disease pathways, find new molecular biomarkers and profile important cell populations down to single cell resolution. As a trusted partner of leading government, academic, pharmaceutical, biotechnology and plant and animal research laboratories globally, the company strives to enhance the quality of life for everyone.